Wondering if Inspire Medical Systems is a bargain at today’s price, or a trap that looks cheaper than it really is? Let us unpack what the recent moves and the fundamentals are actually telling us about value.
The stock has bounced hard in the short term, up about 10% over the last week and roughly 64.7% over the last month, even though it is still down around 26.9% over the past year.
That swing has come as investors refocus on Inspire’s role in treating obstructive sleep apnea with its implantable neurostimulation system, a niche that still has plenty of room to grow. The market has also been reacting to broader sentiment shifts toward high growth, high multiple medtech names, which can quickly change how investors price future…
